News & Events about Globus Medical Inc.
Globus Medical (NYSE:GMED Get Rating) had its price target lifted by Truist Financial from $74.00 to $85.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the medical device companys stock. Several other analysts have ...
Ticker Report
3 months ago
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. trimmed its position in shares of Globus Medical, Inc. (NYSE:GMED Get Rating) by 14.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned ...
Globus Medical, Inc. (NYSE:GMED Get Rating) has been given a consensus rating of Moderate Buy by the thirteen analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the ...
Ticker Report
4 months ago
New Mexico Educational Retirement Board cut its holdings in Globus Medical, Inc. (NYSE:GMED Get Rating) by 21.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,500 shares of the medical device companys stock after...
Ticker Report
5 months ago
Bank of New York Mellon Corp cut its stake in shares of Globus Medical, Inc. (NYSE:GMED Get Rating) by 0.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 804,665 shares of the ...